NORD Top Banner Oct 9-11

Hematologic Disorders

Jul 31, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, News

Promising Phase 2 Trial Results for Patients With Myelodysplastic Syndrome and AML

Jennifer Elliott, PhD, Global Project Leader at Takeda…

Jul 30, 2020| Posted in: Cancers, Hematologic Disorders, Treatment

Typical Treatment Plan for Polycythemia Vera Patients

Ronald Hoffman, MD, Director of the Myeloproliferative Diseases…

Jul 29, 2020| Posted in: Congenital And Genetic Conditions, Hematologic Disorders, Treatment

Expanding Treatment Options for Sickle Cell Disease Patients

Jonathan Sorof, MD, Senior Vice President, Head of…

Jul 28, 2020| Posted in: Congenital And Genetic Conditions, Diagnosis, Gastrointestinal Diseases, Heart Diseases, Hematologic Disorders, Kidney And Urinary Diseases, Lysosomal Storage Disorders, Metabolic Disorders, Neurology/Nervous System Diseases, Ophthalmology/Eye Diseases, Skin Conditions

Fabry Disease and the Heart

Ozlem Goker-Alpan, MD, provides a summary of research…

Jul 25, 2020| Posted in: Cancers, Hematologic Disorders, News, Regulations, Treatment

FDA Approves CAR T Therapy for Mantle Cell Lymphoma

The U.S. Food and Drug Administration (FDA) has…

Jul 24, 2020| Posted in: Congenital And Genetic Conditions, Drug Development, Hematologic Disorders, Metabolic Disorders

Paroxysmal Nocturnal Hemoglobinuria (PNH) Explained

Federico Grossi, MD, chief medical officer at Apellis…

Jul 22, 2020| Posted in: Advocacy, Cancers, Diagnosis, Hematologic Disorders

Lymphoma Research Foundation Overview

Meghan Gutierrez, chief executive officer of the Lymphoma…

Jul 20, 2020| Posted in: Autoimmune / Autoinflammatory Disorders, Congenital And Genetic Conditions, Hematologic Disorders, News

How COVID-19 Has Affected Sickle Cell Disease Patients

Jonathan Sorof, MD, Head of Medical Affairs at…

Jul 17, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, Treatment

Follicular Lymphoma: Diagnosis, Prognosis, and Treatment

John Leonard, MD of Weill Cornell Medicine discusses…

Jul 10, 2020| Posted in: Cancers, Drug Development, Hematologic Disorders, Treatment

Real Data on Efficacy of Transitioning to Ixazomib-Based Treatment for Multiple Myeloma

Steve Noga, MD, of Takeda Oncology discusses the…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

TTR Amyloidosis CME Program

Morie A Gertz, MD, MACP provides an overview of TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent disease progression – through these brief courses that are certified for CME credit.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.

Heather Lau, MD, MS, NYU School of Medicine, New York, NY
Morie A Gertz, MD, Mayo Clinic, Rochester, MN
Timothy Craig, DO, Penn State University, Hershey, PA
Eric T. Wong, MD, Harvard Medical School, Boston, MA

Hematologic Disorders

Topics